Literature DB >> 16198767

Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study.

Ronald H Gray1, Xianbin Li, Godfrey Kigozi, David Serwadda, Heena Brahmbhatt, Fred Wabwire-Mangen, Fred Nalugoda, Mohamed Kiddugavu, Nelson Sewankambo, Thomas C Quinn, Steven J Reynolds, Maria J Wawer.   

Abstract

BACKGROUND: HIV acquisition is significantly higher during pregnancy than in the postpartum period. We did a prospective study to estimate HIV incidence rates during pregnancy and lactation.
METHODS: We assessed 2188 HIV-negative sexually active women with 2625 exposure intervals during pregnancy and 2887 intervals during breastfeeding, and 8473 non-pregnant and non-lactating women with 24,258 exposure intervals. Outcomes were HIV incidence rates per 100 person years and incidence rate ratios estimated by Poisson multivariate regression, with the non-pregnant or non-lactating women as the reference group. We also assessed the husbands of the married women to study male risk behaviours.
FINDINGS: HIV incidence rates were 2.3 per 100 person years during pregnancy, 1.3 per 100 person years during breastfeeding, and 1.1 per 100 person years in the non-pregnant and non-lactating women. The adjusted incidence rate ratios were 2.16 (95% CI 1.39-3.37) during pregnancy and 1.16 (0.82-1.63) during breastfeeding. Pregnant women and their male partners reported significantly fewer external sexual partners than did the other groups. In married pregnant women who had a sexual relationship with their male spouses, the HIV incidence rate ratio was 1.36 (0.63-2.93). In married pregnant women in HIV-discordant relationships (ie, with HIV-positive men) the incidence rate ratio was 1.76 (0.62-4.03).
INTERPRETATION: The risk of HIV acquisition rises during pregnancy. This change is unlikely to be due to sexual risk behaviours, but might be attributable to hormonal changes affecting the genital tract mucosa or immune responses. HIV prevention efforts are needed during pregnancy to protect mothers and their infants.

Entities:  

Mesh:

Year:  2005        PMID: 16198767     DOI: 10.1016/S0140-6736(05)67481-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  153 in total

1.  Pharmacokinetics and placental transfer of single-dose tenofovir 1% vaginal gel in term pregnancy.

Authors:  Richard Beigi; Lisa Noguchi; Teresa Parsons; Ingrid Macio; Ratiya P Kunjara Na Ayudhya; Jianmeng Chen; Craig W Hendrix; Benoît Mâsse; Megan Valentine; Jeanna Piper; D Heather Watts
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

Review 2.  Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis.

Authors:  Dionne P Robinson; Sabra L Klein
Journal:  Horm Behav       Date:  2012-03-03       Impact factor: 3.587

3.  In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women.

Authors:  Brenna L Anderson; Mimi Ghosh; Christina Raker; John Fahey; Yan Song; Dwight J Rouse; Charles R Wira; Susan Cu-Uvin
Journal:  Am J Obstet Gynecol       Date:  2012-04-30       Impact factor: 8.661

4.  The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.

Authors:  Brenna L Hughes; Riana Dutt; Christina Raker; Melody Barthelemy; Richard M Rossoll; Bharat Ramratnam; Charles R Wira; Susan Cu-Uvin
Journal:  Am J Obstet Gynecol       Date:  2016-07-05       Impact factor: 8.661

Review 5.  HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.

Authors:  Viviana Simon; David D Ho; Quarraisha Abdool Karim
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

Review 6.  Measuring trends in prevalence and incidence of HIV infection in countries with generalised epidemics.

Authors:  P D Ghys; E Kufa; M V George
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

7.  Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting.

Authors:  Nivashnee Naicker; Ayesha B M Kharsany; Lise Werner; Francois van Loggerenberg; Koleka Mlisana; Nigel Garrett; Salim S Abdool Karim
Journal:  AIDS Behav       Date:  2015-07

Review 8.  Delivering preexposure prophylaxis to pregnant and breastfeeding women in Sub-Saharan Africa: the implementation science frontier.

Authors:  Dvora L Joseph Davey; Linda-Gail Bekker; Pamina M Gorbach; Thomas J Coates; Landon Myer
Journal:  AIDS       Date:  2017-10-23       Impact factor: 4.177

9.  Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.

Authors:  Jordan K Kyongo; Tania Crucitti; Joris Menten; Liselotte Hardy; Piet Cools; Johan Michiels; Sinead Delany-Moretlwe; Mary Mwaura; Gilles Ndayisaba; Sarah Joseph; Raina Fichorova; Janneke van de Wijgert; Guido Vanham; Kevin K Ariën; Vicky Jespers
Journal:  Clin Vaccine Immunol       Date:  2015-03-11

Review 10.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.